Description

Enoxaparin Sodium EP

Enoxaparin Sodium EP is a high-purity low molecular weight heparin used in pharmaceutical formulations for the prevention and treatment of thromboembolic disorders. Compliant with European Pharmacopoeia (EP) standards, it is widely utilized in surgical, medical, and cardiovascular settings due to its predictable anticoagulant activity and favorable safety profile.
Enoxaparin Sodium is produced by alkaline depolymerization of Heparin derived from porcine intestinal mucosa, followed by fractionation to achieve a defined molecular weight distribution. It appears as a white to off-white hygroscopic powder that is freely soluble in water, making it suitable for injectable formulations.
In pharmaceutical and clinical applications, Enoxaparin Sodium EP is used in:
• Prophylaxis of deep vein thrombosis following surgery or immobilization
• Treatment of acute venous thromboembolism
• Prevention of ischemic complications in acute coronary syndromes
• Anticoagulation during hemodialysis
• Management of thrombotic risk in oncology patients
• Clinical research involving anticoagulant therapies
Enoxaparin Sodium EP exerts its anticoagulant effect primarily by potentiating antithrombin-mediated inhibition of Factor Xa, with limited activity against thrombin (Factor IIa). This selective mechanism results in predictable anticoagulation and reduced need for routine monitoring compared to unfractionated Heparin.
CarboMer supplies Enoxaparin Sodium EP with control over molecular weight distribution, anti-Xa activity, purity, sulfate content, and microbial quality. The material meets EP monograph specifications and is suitable for regulated pharmaceutical manufacturing and clinical use.
The material is packaged in sealed, moisture-protective, tamper-evident containers and handled under controlled conditions. Available in laboratory, pilot, and commercial-scale quantities. Documentation includes Certificate of Analysis (CoA), Safety Data Sheet (SDS), and full traceability.
Each batch is tested for identity, anti-Xa potency, molecular weight profile, pH, water content, endotoxins, and microbial limits. Technical support is available to assist with formulation considerations, stability, and regulatory compliance.
As with all CarboMer supplied anticoagulant ingredients, Enoxaparin Sodium EP is supported by dependable global supply, rigorous quality control, and expert technical guidance to ensure safe, effective, and compliant pharmaceutical product development.